Previous reports showed that androgen ablation affected the expression level of p-glycoprotein (ABCB1), Myxovirus resistanse A (MxA), and Y-box binding protein-1 (YB-1) in prostate cancer cell [25–29]. This evidence concerns the gene YBX1 and prostate carcinoma.